These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis. Silverberg JI; Adam DN; Zirwas M; Kalia S; Gutermuth J; Pinter A; Pink AE; Chiricozzi A; Barbarot S; Mark T; Tindberg AM; Weidinger S Am J Clin Dermatol; 2022 Jul; 23(4):547-559. PubMed ID: 35857179 [TBL] [Abstract][Full Text] [Related]
4. Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. Chu DK; Chu AWL; Rayner DG; Guyatt GH; Yepes-Nuñez JJ; Gomez-Escobar L; Pérez-Herrera LC; Díaz Martinez JP; Brignardello-Petersen R; Sadeghirad B; Wong MM; Ceccacci R; Zhao IX; Basmaji J; MacDonald M; Chu X; Islam N; Gao Y; Izcovich A; Asiniwasis RN; Boguniewicz M; De Benedetto A; Capozza K; Chen L; Ellison K; Frazier WT; Greenhawt M; Huynh J; LeBovidge J; Lio PA; Martin SA; O'Brien M; Ong PY; Silverberg JI; Spergel JM; Smith Begolka W; Wang J; Wheeler KE; Gardner DD; Schneider L J Allergy Clin Immunol; 2023 Dec; 152(6):1493-1519. PubMed ID: 37678572 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of topical Janus kinase and phosphodiesterase inhibitor-4 inhibitors for the treatment of atopic dermatitis: A network meta-analysis. Zhang L; Du D; Wang L; Guo L; Jiang X J Dermatol; 2021 Dec; 48(12):1877-1883. PubMed ID: 34487567 [TBL] [Abstract][Full Text] [Related]
6. Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis. Fröschl B; Arts D; Leopold C GMS Health Technol Assess; 2007 Sep; 3():Doc09. PubMed ID: 21289943 [TBL] [Abstract][Full Text] [Related]
7. Therapy of atopic eczema. Werfel T; Claes C; Kulp W; Greiner W; von der Schulenburg JM GMS Health Technol Assess; 2006 Oct; 2():Doc19. PubMed ID: 21289970 [TBL] [Abstract][Full Text] [Related]
8. Short-term efficacy and safety of biologics and Janus kinase inhibitors for patients with atopic dermatitis: A systematic review and meta-analysis. Chen Q; Cui L; Hu Y; Chen Z; Gao Y; Shi Y Heliyon; 2023 Nov; 9(11):e22014. PubMed ID: 38034798 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial. Reich K; Teixeira HD; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Werfel T; Zeng J; Huang X; Hu X; Hendrickson BA; Ladizinski B; Chu AD; Silverberg JI Lancet; 2021 Jun; 397(10290):2169-2181. PubMed ID: 34023009 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial. Simpson EL; Silverberg JI; Thyssen JP; Viguier M; Thaçi D; de Bruin-Weller M; Weidinger S; Chan G; DiBonaventura M; Biswas P; Feeney C; Koulias C; Cork MJ Am J Clin Dermatol; 2023 Jul; 24(4):609-621. PubMed ID: 37213005 [TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of topical calcineurin inhibitors in adult patients with atopic dermatitis. Frankel HC; Qureshi AA Am J Clin Dermatol; 2012 Apr; 13(2):113-23. PubMed ID: 22263704 [TBL] [Abstract][Full Text] [Related]
12. Delgocitinib in atopic dermatitis. Ho J; Molin S Drugs Today (Barc); 2021 Dec; 57(12):719-731. PubMed ID: 34909801 [TBL] [Abstract][Full Text] [Related]
13. An Open-Label Prospective Study to Compare the Efficacy and Safety of Topical Fluticasone Versus Tacrolimus in the Proactive Treatment of Atopic Dermatitis. Mudaliyar VR; Pathak A; Dixit A; Kumar SS Dermatol Pract Concept; 2020 Oct; 10(4):e2020094. PubMed ID: 33150035 [TBL] [Abstract][Full Text] [Related]
14. Intermittent or Sequential Topical Tacrolimus in Atopic Dermatitis: Systematic Review and Meta-Analysis. Dhar S; De A; Saha A; Chitnis KR; Mane A; Dhoot D; Barkate H Cureus; 2023 Dec; 15(12):e50640. PubMed ID: 38229798 [TBL] [Abstract][Full Text] [Related]
15. Review of Atopic Dermatitis and Topical Therapies. Mayba JN; Gooderham MJ J Cutan Med Surg; 2017; 21(3):227-236. PubMed ID: 28300440 [TBL] [Abstract][Full Text] [Related]
16. Comparative Efficacy of Targeted Systemic Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-analysis. Silverberg JI; Hong HC; Calimlim BM; Lee WJ; Teixeira HD; Collins EB; Crowell MM; Johnson SJ; Armstrong AW Dermatol Ther (Heidelb); 2023 Oct; 13(10):2247-2264. PubMed ID: 37658223 [TBL] [Abstract][Full Text] [Related]
17. Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas. Draelos ZD Curr Med Res Opin; 2008 Apr; 24(4):985-94. PubMed ID: 18284804 [TBL] [Abstract][Full Text] [Related]
18. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and economics of topical calcineurin inhibitors for the treatment of atopic dermatitis. Abramovits W; Hung P; Tong KB Am J Clin Dermatol; 2006; 7(4):213-22. PubMed ID: 16901181 [TBL] [Abstract][Full Text] [Related]
20. Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitis. Thyssen JP; Bieber T; Kleyn CE; Nosbaum A; Grond S; Petto H; Riedl E; Wollenberg A J Dermatolog Treat; 2023 Dec; 34(1):2216322. PubMed ID: 37345379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]